iwNHL 2016: Highlights from Day 1 by Catherine Bollard
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Diffuse Large B-Cell Lymphoma
View expert index
View all diseases
View all trials
View all medicines
EMMA Vienna 2017
View upcoming conferences
View previous conferences
What’s next for Richter’s syndrome?
Barbara Eichhorst, MD, from the University of Cologne, Cologne, Germany, discusses the challenges of treating Richter’s syndrome at the 2017…
PHILEMON: a step closer to using MRD to guide treatment decisions in mantle cell lymphoma (MCL)?
Carsten Niemann, MD, PhD, from the Rigshospitalet, Copenhagen, Denmark, introduces the Phase II PHILEMON trial (NCT02460276) of ibrutinib, lenalidomide and…
What is the focus of lymphoma research in 2017?
Anas Younes, MD, from the Memorial Sloan Kettering Cancer Center, New York, NY, discusses future directions of lymphoma research at…
Temsirolimus with BERT for the treatment of relapsed mantle cell and follicular lymphoma
Georg Hess, MD, from the Johannes Gutenberg University, Mainz, Germany, discusses the final results of a Phase I/II trial of…
BSH 2017 lymphoma highlights: looking at synergies between immuno-oncology agents
Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil of Oxford University Hospitals NHS Foundation Trust, Oxford, UK discusses his highlights from…
Advice on how to help patients with fatigue after cancer treatment
Marije van der Lee
Marije van der Lee, Phd from the Helen Dowling Institute, Utrecht, Netherlands provides advice to clinicians who treat patients with…
The molecular genetics of follicular lymphoma
Jessica Okosun, MA, MB, BChir, PhD, MRCP, FRCPath of Barts Cancer Institute, London, UK discusses the molecular genetics of follicular…
Fatigue after lymphoma treatment – overview of effective interventions
Marije van der Lee
Marije van der Lee, Phd from the Helen Dowling Institute, Utrecht, Netherlands gives an overview of her talk on fatigue…
Overview of the International Conference on Malignant Lymphoma (ICML) 2017
Franco Cavalli, MD, FRCP from the Oncology Institute of Southern Switzerland, Bellinzona, Switzerland gives an overview of the main topics…
Ibrutinib combined with TGR-1202 in CLL and mantle cell lymphoma (MCL): preliminary results
Jennifer R. Brown, MD, PhD, from the Dana-Farber Cancer Institute, Boston, MA, outlines the preliminary results of the Phase I…
Sign up for the latest news and videos
Is CLL curable today?
How far are we from a cure for CLL?
Mechanism of action of venetoclax (ABT-199) and its side effects
Myeloma 2016: Panel discussion on novel treatments
Highlights from the International Workshop of the German CLL Study Group